Contact Us FAQ  Useful links

 

 

 

ethical Guidelines

Nusantara Bioscience has agreed to follow the ethical standards as determined by the Committee on Publication Ethics (COPE) as well as International Committee of Medical Journal Editors (ICMJE). Author(s) must obedient and pay attention to the authorship, plagiarism, duplicate (redundant) publication, fabrication of data, manipulation of citation, as well as ethical approval and Intelectual Property Rights.

Authorship

Author is a person who participated in the research and sufficient for taking public responsibility for all portions of the content. When authorship is attributed to a group, all authors should have made substantial contributions to the following: (i) conception and design of the research, acquisition of the data, analysis and interpretation of the data; (ii) drafting of the manuscript and its revision; and (iii) final approval of the version to be submitted. Manuscript submission implies that all authors have read and approved the final version of the manuscript, and agree to the manuscript submission to this journal. All authors must be responsible for the quality, accuracy, and ethics of the research. 

Plagiarism

Plagiarism is the practice of taking someone else's work or ideas and passing them off as one's own. Submitted manuscripts should be the original works of the author(s).

Duplicate (redundant) publication

Duplicate publication is publication of a paper that overlaps substantially with one already published, without clear, visible reference to the previous publication. Manuscript submissions will be considered for publication only if they are submitted solely to this journal and do not overlap substantially with a published article. Any manuscript that has (near) similar hypothesis, sample characteristics, methodology, results, and conclusions to a published article is a duplicate article and is prohibited, even if it is published in different languages. The slicing of data from a "single research" to make some individuals manuscript whitout substantial differences should be avoided.

Fabrication of data

Fabrication, manipulation or falsification of data is an ethical violation and is prohibited.

Citations manipulation

The only relevant citations are used in the manuscripts.  Irrelevant (self) citation to increase author(s)'s citation (h-index) or unnecessary citation to improve the references are not allowed.

Ethic approval

Experiments held on human and animals must obtain permission from the official agencies and does not violate the law. Human or animal related experiments should be published in "Materials and Methods", then examined and got approved by professionals from the side of moral aspect. Researches on human beings must comply with the principles of the Declaration of Helsinki and its recommendations guiding physicians in biomedical research involving human subjects. Human details may be included only if they are essential for scientific purposes and the author(s) obtain written permission from the individual, parent or guardian.

Intellectual Property Right

Author(s) must obedient to the law and/or ethics in treating the object of research and pay attention to the legality of material sources and intellectual property rights.

Conflict of interest and source of funding

Author(s) requires to acknowledge all sources of institutional, private and corporate financial support for the research within the manuscript, and notes any potential conflicts of interest.

 

REVIEW PROCESS

The acceptance of a paper implies that it has been reviewed and recommended by at least two reviewers, one of whom is usually from the Editorial Advisory Board. Authors will generally be notified of acceptance, rejection, or need for revision within 2 to 3 months of receipt. Manuscript is rejected, if the content is not in line with the journal scope, does not meet the ethical standards (i.e. false authorship, plagiarism, duplicate publication, fabrication of data and citation manipulation), does not meet the required quality, written in inappropriate format, has incorrect grammar, or ignores correspondence in three months. Manuscripts can also be rejected if there are two reviewers who gave a negative note. The primary criteria for publication are scientific quality and biological or natural conservation significance. The accepted papers will be published in a chronological order. This journal is published in January, April, July, and October (starting on January 2017). However, online publication was done immediately after acceptance.

The review process conducted double blind, where the identity of authors and reviewers are concealed. Information on their identity can only be granted with the consent of both sides. Authors are asked to propose a list of 5-10 names of prospective reviewers. Management may choose to invite them or not. Authors can also propose that someone does not review. Reviewers must have the Scopus-ID or Researcher-ID (Thomson Reuters) or recorded as a corresponding author in this journal. Reviewers may also be invited from journals published by major publishers such as Elsevier or Springer. They must come from different institutions with authors; preferably originating from three different countries. Basically, one can only review once a year. List of the reviewer updated on every middle and end of the year. Therefore, the reviewers in the past year could not be invited; while the Editorial Advisory Board can only be invited by management.

Uncorrected proofs will be sent to the corresponding author by email as .doc or .rtf (not .docx) files for checking and correcting of typographical errors. To avoid delay in publication, corrected proofs should be returned in 7 days. The accepted papers will be published online in a chronological order at any time, but printed in January, April, July, and October.

 

Copyright

Submission of a manuscript implies that the submitted work has not been published before (except as part of a thesis or report, or abstract); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors. If and when the manuscript is accepted for publication, the author(s) still hold the copyright and retain publishing rights without restrictions. Authors or others are allowed to multiply article as long as not for commercial purposes. For the new invention, authors are suggested to manage its patent before published.

 

Open access

The journal is committed to free-open access that does not charge readers or their institutions for access. Readers are entitled to read, download, copy, distribute, print, search, or link to the full texts of articles, as long as not for commercial purposes. The license type is CC-BY-NC-SA.

 

Disclaimer

No responsibility is assumed by publisher and co-publishers, nor by the editors for any injury and/or damage to persons or property as a result of any actual or alleged libelous statements, infringement of intellectual pro-perty or privacy rights, or products liability, whether resulting from negligence or otherwise, or from any use or operation of any ideas, instructions, procedures, products or methods contained in the material therein.

 
 
Home   |   Archives   |   Contact Us    |   Affiliate Program
Copyright 2014, Nusantara Bioscience. All Rights Reserved